ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

John & Florence Antione To Leave NCI for Jobs At Loma Linda Univ.

June 21, 1991

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase

February 27, 2004

Black Men Face Disparate Cancer Burden; Minority Rates Vary, Klausner Tells House

April 3, 1998

Hopkins Oncology Center Renamed To Honor Sidney Kimmel

May 10, 2002

President’s Cancer Panel Special Commission On Breast Cancer Named

April 25, 1992